Structure Therapeutics, Inc. (GPCR)
21.08
-1.11
(-5.00%)
USD |
NASDAQ |
Oct 16, 16:00
21.07
-0.01
(-0.05%)
After-Hours: 20:00
Structure Therapeutics Free Cash Flow (Quarterly) : -120.34M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -120.34M |
| March 31, 2026 | 14.09M |
| December 31, 2025 | -66.19M |
| September 30, 2025 | -52.62M |
| June 30, 2025 | -54.98M |
| March 31, 2025 | -52.62M |
| December 31, 2024 | -36.45M |
| September 30, 2024 | -20.55M |
| June 30, 2024 | -26.79M |
| Date | Value |
|---|---|
| March 31, 2024 | -34.19M |
| December 31, 2023 | -23.07M |
| September 30, 2023 | -21.54M |
| June 30, 2023 | -16.80M |
| March 31, 2023 | -20.18M |
| December 31, 2022 | |
| June 30, 2022 | -9.890M |
| March 31, 2022 | -13.53M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Eli Lilly & Co. | 4.475B |
| Novo Nordisk A/S | 6.362B |
| Pfizer Inc. | 302.00M |
| Viking Therapeutics, Inc. | -125.17M |
| Liquidia Corp. | 69.01M |